Abstract Number: 37 • 2018 ACR/ARHP Annual Meeting
Discovery of DWP213388, a Potent ITK and BTK Dual Target Inhibitor with Excellent Efficacy, As a Treatment for Autoimmune Diseases
Background/Purpose: Interleukin-2-inducible T-cell Kinase (ITK) and Bruton's tyrosine kinase (BTK) are critical for B cells and T cells activation, and dysregulation of this process has…